探讨新冠病毒疫苗基因优先排序的伦理问题。
Exploring the ethics of genetic prioritisation for COVID-19 vaccines.
机构信息
Wellcome Centre for Ethics and Humanities and Ethox Centre, Nuffield Department of Population Health, University of Oxford, Big Data Institute, Oxford, OX3 7LF, USA.
出版信息
Eur J Hum Genet. 2022 Aug;30(8):875-879. doi: 10.1038/s41431-022-01058-1. Epub 2022 Mar 7.
Abstract
There is evidence to suggest that host genomic factors may account for disease response variability in COVID-19 infection. In this paper, we consider if and how host genomics should influence decisions about vaccine allocation. Three potential host genetic factors are explored: vulnerability to infection, resistance to infection, and increased infectivity. We argue for the prioritisation of the genetically vulnerable in vaccination schemes, and evaluate the potential for ethical de-prioritisation of individuals with genetic markers for resistance. Lastly, we discuss ethical prioritisation of individuals with genetic markers for increased infectivity (those more likely to spread COVID-19).
摘要
有证据表明，宿主基因组因素可能导致 COVID-19 感染中的疾病反应变异性。在本文中，我们考虑宿主基因组学是否以及如何影响疫苗分配决策。探讨了三个潜在的宿主遗传因素：易感染性、抗感染性和传染性增加。我们主张在疫苗接种计划中优先考虑遗传脆弱者，并评估具有抗感染遗传标志物的个体在伦理上被优先排序的可能性。最后，我们讨论了具有增加传染性遗传标志物（更有可能传播 COVID-19 的个体）的个体的伦理优先排序。
相似文献
1
Exploring the ethics of genetic prioritisation for COVID-19 vaccines.探讨新冠病毒疫苗基因优先排序的伦理问题。
Eur J Hum Genet. 2022 Aug;30(8):875-879. doi: 10.1038/s41431-022-01058-1. Epub 2022 Mar 7.
2
Why we should not 'just use age' for COVID-19 vaccine prioritisation.为什么我们不应该“仅仅依据年龄”来为 COVID-19 疫苗接种进行优先级排序。
J Med Ethics. 2022 Aug;48(8):538-541. doi: 10.1136/medethics-2021-107443. Epub 2021 Jul 9.
3
A conceptual approach to the rationale for SARS-CoV-2 vaccine allocation prioritisation.一种用于 SARS-CoV-2 疫苗分配优先级排序的基本原理的概念方法。
Pathog Glob Health. 2021 Jul;115(5):273-276. doi: 10.1080/20477724.2021.1932136. Epub 2021 Jun 9.
4
Vaccination as an Equaliser? Evaluating COVID-19 Vaccine Prioritisation and Compensation.接种疫苗能实现公平吗？评估 COVID-19 疫苗的优先顺序和补偿。
Med Law Rev. 2022 Dec 8;30(4):584-609. doi: 10.1093/medlaw/fwac020.
5
Justice in COVID-19 vaccine prioritisation: rethinking the approach.在 COVID-19 疫苗优先排序中的公正：重新思考方法。
J Med Ethics. 2021 Sep;47(9):623-631. doi: 10.1136/medethics-2020-107117. Epub 2021 Jun 9.
6
US adults' preferences for race-based and place-based prioritisation for COVID-19 vaccines.美国成年人对基于种族和基于地点的 COVID-19 疫苗优先接种的偏好。
J Med Ethics. 2022 Jul;48(7):497-500. doi: 10.1136/medethics-2021-107741. Epub 2021 Dec 31.
7
Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort study in England.因免疫抑制药物治疗或移植手术而处于临床风险中的个体接种 COVID-19 疫苗的吸收率、效果和安全性：一项基于人群的英格兰队列研究。
BMC Med. 2024 Jun 10;22(1):237. doi: 10.1186/s12916-024-03457-1.
8
COVID-19: vaccination problems.新型冠状病毒肺炎：疫苗接种问题。
Environ Microbiol. 2021 Jun;23(6):2878-2890. doi: 10.1111/1462-2920.15549. Epub 2021 May 14.
9
The impact of prioritisation and dosing intervals on the effects of COVID-19 vaccination in Europe: an agent-based cohort model.在欧洲，优先排序和给药间隔对 COVID-19 疫苗接种效果的影响：基于代理的队列模型。
Sci Rep. 2021 Sep 22;11(1):18812. doi: 10.1038/s41598-021-98216-0.
10
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.针对 SARS-CoV-2 的疫苗在国内的年龄优先排序、全球分配和对公共卫生的影响：一项数学建模分析。
Vaccine. 2021 May 21;39(22):2995-3006. doi: 10.1016/j.vaccine.2021.04.002. Epub 2021 Apr 8.
引用本文的文献
1
Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities.SARS-CoV-2 人类受体基因内的多态性与不同种族间的可变疾病结局相关。
Genes (Basel). 2023 Sep 14;14(9):1798. doi: 10.3390/genes14091798.
2
Nucleotides Entrapped in Liposome Nanovesicles as Tools for Therapeutic and Diagnostic Use in Biomedical Applications.包裹在脂质体纳米囊泡中的核苷酸作为生物医学应用中治疗和诊断工具。
Pharmaceutics. 2023 Mar 8;15(3):873. doi: 10.3390/pharmaceutics15030873.
本文引用的文献
1
Host/genetic factors associated with COVID-19 call for precision medicine.与新冠肺炎相关的宿主/遗传因素需要精准医学。
Precis Clin Med. 2020 Jul 21;3(3):228-234. doi: 10.1093/pcmedi/pbaa026. eCollection 2020 Sep.
2
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.鉴定 LZTFL1 为 COVID-19 风险位点的候选效应基因。
Nat Genet. 2021 Nov;53(11):1606-1615. doi: 10.1038/s41588-021-00955-3. Epub 2021 Nov 4.
3
Genetic Screening for Variants in Young and Previously Healthy Men With Severe COVID-19.对患有严重 COVID-19 的年轻且既往健康男性的变异进行遗传筛查。
Front Immunol. 2021 Jul 23;12:719115. doi: 10.3389/fimmu.2021.719115. eCollection 2021.
4
Ethically utilising COVID-19 host-genomic data.道德地利用新冠病毒宿主基因组数据。
NPJ Genom Med. 2021 May 10;6(1):31. doi: 10.1038/s41525-021-00194-9.
5
Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.在不断变化的社会和流行病学背景下优先考虑 COVID-19 疫苗接种：一项数学建模研究。
Lancet Infect Dis. 2021 Aug;21(8):1097-1106. doi: 10.1016/S1473-3099(21)00057-8. Epub 2021 Mar 31.
6
How should we conduct pandemic vaccination?我们应该如何开展大流行疫苗接种？
Vaccine. 2021 Feb 5;39(6):994-999. doi: 10.1016/j.vaccine.2020.12.059. Epub 2021 Jan 8.
7
Good reasons to vaccinate: mandatory or payment for risk?有充分理由接种疫苗：强制接种还是为风险付费？
J Med Ethics. 2021 Feb;47(2):78-85. doi: 10.1136/medethics-2020-106821. Epub 2020 Nov 5.
8
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.与 SARS-CoV-2 感染易感性和 COVID-19 疾病严重程度相关的人类遗传因素。
Hum Genomics. 2020 Oct 22;14(1):40. doi: 10.1186/s40246-020-00290-4.
9
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.严重 COVID-19 的主要遗传风险因素来自尼安德特人。
Nature. 2020 Nov;587(7835):610-612. doi: 10.1038/s41586-020-2818-3. Epub 2020 Sep 30.
10
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
Zotero 插件